Surgery Partners Return on Tangible Equity 2013-2025 | SGRY
Current and historical return on tangible equity values for Surgery Partners (SGRY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Surgery Partners Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $-0.18B | $-1.98B | 9.50% |
| 2025-03-31 | $-0.20B | $-2.02B | 10.59% |
| 2024-12-31 | $-0.17B | $-1.92B | 10.00% |
| 2024-09-30 | $-0.06B | $-1.75B | 3.94% |
| 2024-06-30 | $-0.03B | $-1.68B | 2.36% |
| 2024-03-31 | $0.00B | $-1.41B | -0.07% |
| 2023-12-31 | $-0.01B | $-1.35B | 0.91% |
| 2023-09-30 | $-0.03B | $-1.32B | 2.63% |
| 2023-06-30 | $-0.05B | $-1.31B | 3.64% |
| 2023-03-31 | $-0.09B | $-1.31B | 5.49% |
| 2022-12-31 | $-0.05B | $-1.24B | 2.97% |
| 2022-09-30 | $-0.03B | $-2.08B | 1.55% |
| 2022-06-30 | $-0.03B | $-2.00B | 1.44% |
| 2022-03-31 | $-0.04B | $-1.96B | 1.89% |
| 2021-12-31 | $-0.08B | $-1.99B | 4.01% |
| 2021-09-30 | $-0.09B | $-2.11B | 4.15% |
| 2021-06-30 | $-0.14B | $-2.01B | 6.47% |
| 2021-03-31 | $-0.15B | $-1.97B | 7.08% |
| 2020-12-31 | $-0.16B | $-2.20B | 7.24% |
| 2020-09-30 | $-0.18B | $-2.16B | 8.48% |
| 2020-06-30 | $-0.13B | $-2.15B | 6.34% |
| 2020-03-31 | $-0.12B | $-2.12B | 5.79% |
| 2019-12-31 | $-0.11B | $-2.07B | 5.49% |
| 2019-09-30 | $-0.24B | $-2.07B | 11.84% |
| 2019-06-30 | $-0.24B | $-2.03B | 12.37% |
| 2019-03-31 | $-0.24B | $-2.00B | 12.58% |
| 2018-12-31 | $-0.24B | $-1.98B | 12.68% |
| 2018-09-30 | $-0.12B | $-1.85B | 6.69% |
| 2018-06-30 | $-0.12B | $-1.84B | 7.08% |
| 2018-03-31 | $-0.10B | $-1.81B | 6.25% |
| 2017-12-31 | $-0.08B | $-1.74B | 5.32% |
| 2017-09-30 | $-0.02B | $-1.62B | 1.61% |
| 2017-06-30 | $0.01B | $-1.30B | -0.62% |
| 2017-03-31 | $0.01B | $-1.28B | -1.10% |
| 2016-12-31 | $0.01B | $-1.28B | -0.81% |
| 2016-09-30 | $0.01B | $-1.26B | -0.82% |
| 2016-06-30 | $0.01B | $-1.25B | -0.73% |
| 2016-03-31 | $0.00B | $-1.18B | -0.22% |
| 2015-12-31 | $0.00B | $-1.16B | -0.32% |
| 2015-06-30 | $-0.02B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.057B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.373B | 28.07 |
| CVS Health (CVS) | United States | $89.823B | 11.17 |
| Elevance Health (ELV) | United States | $69.805B | 9.39 |
| Cencora (COR) | United States | $58.879B | 19.61 |
| DiDi Global (DIDIY) | China | $28.380B | 30.15 |
| Labcorp Holdings (LH) | United States | $23.110B | 18.37 |
| Natera (NTRA) | United States | $22.048B | 0.00 |
| BioMerieux (BMXMF) | France | $17.636B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.729B | 0.00 |
| ICON (ICLR) | Ireland | $14.556B | 14.01 |
| Medpace Holdings (MEDP) | United States | $13.083B | 34.63 |
| Solventum (SOLV) | United States | $12.631B | 13.03 |
| CochLear (CHEOY) | Australia | $12.527B | 0.00 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Revvity (RVTY) | United States | $10.644B | 18.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.863B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.237B | 0.00 |
| Avantor (AVTR) | United States | $8.781B | 12.88 |
| Charles River Laboratories (CRL) | United States | $7.854B | 14.90 |
| HealthEquity (HQY) | United States | $7.700B | 33.73 |
| Bausch + Lomb (BLCO) | Canada | $5.147B | 34.62 |
| Sotera Health (SHC) | United States | $4.630B | 25.87 |
| BrightSpring Health Services (BTSG) | United States | $4.186B | 31.93 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.455B | 79.14 |
| Alignment Healthcare (ALHC) | United States | $2.974B | 0.00 |
| Concentras Parent (CON) | United States | $2.966B | 18.81 |
| Organon (OGN) | United States | $2.436B | 2.65 |
| Premier (PINC) | United States | $2.104B | 19.50 |
| Progyny (PGNY) | United States | $1.940B | 41.02 |
| Ardent Health (ARDT) | United States | $1.863B | 7.19 |
| PACS (PACS) | United States | $1.817B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.518B | 25.71 |
| Pediatrix Medical (MD) | United States | $1.417B | 9.46 |
| Teladoc Health (TDOC) | United States | $1.276B | 0.00 |
| Omada Health (OMDA) | $1.240B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.132B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.812B | 4.76 |
| AMN Healthcare Services Inc (AMN) | United States | $0.778B | 9.62 |
| CareDx (CDNA) | United States | $0.648B | 11.93 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.515B | 7.80 |
| Agilon Health (AGL) | United States | $0.501B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.482B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 7.01 |
| SBC Medicals (SBC) | United States | $0.413B | 9.07 |
| So-Young (SY) | China | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.411B | 27.03 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.391B | 0.00 |
| Oncology Institute (TOI) | United States | $0.334B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.157B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.116B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| KindlyMD (NAKA) | United States | $0.076B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| ModivCare (MODV) | United States | $0.027B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |